Abstracts - Society for Developmental Biology
Abstracts - Society for Developmental Biology
Abstracts - Society for Developmental Biology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
125<br />
versus asymmetric cell divisions critical to cell fate decisions. A polarity complex composed of the proteins aPKC-Par6-<br />
Par3 maintains active Notch signaling in the most apical domain of rosette neural stem cells. Notch signaling is inhibited at<br />
basolateral portions of the cell by Numb. We show here that inhibition of Notch signaling by treatment with the gammasecretase<br />
inhibitor DAPT results in a reduction in symmetrical cell divisions and an increase in asymmetrical cell divisions,<br />
and there<strong>for</strong>e increased production of neurons relative to neural stem cells. We also demonstrate that treatment with<br />
aurothiomalate (ATM), a small molecule inhibitor that prevents <strong>for</strong>mation of a functional aPKC-Par6-Par3 polarity<br />
complex, disrupts the subcellular localization of Par3 and Numb and reduces the number of asymmetric cell division<br />
events. Under these conditions, the extent of neuron production is reduced. Additionally, we show that rosettes require<br />
active maintenance of apical/basal polarity, as ATM treatment disrupts these structures.<br />
Program/Abstract # 377<br />
The Bmp antagonist Noggin paradoxically induces the chondrogenic program in post-migratory, neural crestderived<br />
facial mesenchyme<br />
Buchtova, Marcela, Academy of Sciences Instit of Animal Physiology & Genetics, BRNO Czech Republic; Richman, Joy<br />
(University of British Columbia, Vancouver, Canada)<br />
The bone morphogenetic protein (BMP) antagonist, Noggin, and Retinoic acid (RA) have previously been shown to induce<br />
a homeotic trans<strong>for</strong>mation within the face of chicken embryos. The maxillary prominence was converted into the<br />
frontonasal mass, thereby duplicating the facial midline. (Lee et al. 2001). The phenotype consists of the <strong>for</strong>mation of an<br />
ectopic cartilage which acquires the identity of the interorbital septum. Here, we examined the genesis of the cartilage and<br />
determined that a Noggin bead alone was sufficient to induce the cartilage. This trans<strong>for</strong>mation from osteogenic to<br />
chondrogenic fate only occurred in stage 15 embryos. By stage 20, treated embryos lost various intramembranous bones in<br />
the palate but did not <strong>for</strong>m cartilage. To test whether Noggin could directly activate the chondrogenic program we created<br />
micromass cultures from stage 15 and 20 maxillary prominence, transfected a Col2-Luciferase reporter gene, which is<br />
based on the binding site <strong>for</strong> SOX5, SOX6 and SOX9 in Col2a1. Noggin treatment of stage 15 mesenchyme significantly<br />
stimulated the reporter whereas Noggin treatment at stage 20 had no effect on Col2-LUC activity. The induction of SOX9<br />
RNA by Noggin at stage 15 but not at stage 20 mirrored the stage-specific results from the luciferase reporter experiments.<br />
Our results suggest that Noggin at early stages of craniofacial development takes on a different role, unrelated to being a<br />
BMP antagonist. Instead, Noggin activates transcription factors that promote chondrogenesis. We conclude that the<br />
response of the mesenchyme is altered at stage 20 due to changes in the molecular landscape. This work was supported by<br />
GACR (grant 304/09/0725) to MB and CIHR grant toJMR.<br />
Program/Abstract # 378<br />
The Hippo pathway member Nf2 regulates trophectoderm/inner cell mass specification.<br />
Cockburn, Katherine; Rossant, Janet,University of Toronto, Toronto Canada<br />
The first lineages to be specified during mouse preimplantation development are the trophectoderm (TE) and the inner cell<br />
mass (ICM). Proper segregation of these two lineages requires that TE-specific transcription factors such as Cdx2 be<br />
restricted in their expression to the outer, future-TE cells of the embryo. This Cdx2 expression pattern is regulated by the<br />
transcriptional co-activator Yap, whose nuclear localization and resulting transcriptional activity is controlled by the<br />
kinases Lats 1 and 2 (Lats1/2). The factors acting upstream of Lats1/2, Yap and Cdx2 during TE/ICM specification have<br />
not yet been described. Here, we demonstrate a role <strong>for</strong> the Hippo scaffolding protein Nf2 in the preimplantation embryo.<br />
Injection of a dominant negative <strong>for</strong>m of Nf2 (dnNf2) causes a cell autonomous accumulation of Yap in the nuclei of<br />
inside cells of the embryo, where it is normally cytoplasmic, and an increase in Cdx2 expression in these cells, where it is<br />
usually absent. Consistent with an role upstream of Lats1/2, the effects of dnNf2 injection can be rescued by overexpression<br />
of wild-type Lats2. In contrast to the strong and consistent effects of dnNf2 injection, we find that Nf2-/-<br />
embryos have mild defectsin Yap localization and Cdx2 expression, and that these defects become more severe as<br />
blastocyst development proceeds. Additionally, in wildtype embryos, Nf2 mRNA and protein can be detected be<strong>for</strong>e the<br />
onset of zygotic transcription, suggesting that maternally supplied Nf2 is masking a stronger phenotype in these mutants.<br />
Taken together, our results demonstrate that Nf2 acts upstream of Lats1/2 and Yap to regulate Cdx2, and that maternally<br />
supplied Nf2 may play an important role during TE/ICM specification.<br />
Program/Abstract # 379<br />
Identification of transcription factors involved in differentiation of late-born ventral spinal neurons<br />
Di Bella, Daniela, Fundación Instituto Leloir, Buenos AiresArgentina; Carcagno, Abel; Petracca, Yanina; Sartoretti,<br />
Micaela (Fundación Instituto Leloir, Buenos Aires, Argentina); Goulding, Martyn (Salk Institute, La Jolla, CA, United<br />
States); Lanuza, Guillermo (Fundación Instituto Leloir, Buenos Aires, Argentina)